In 4 phase III, controlled, open-label clinical studies, fever and shivering were more commonly reported when pneumococcal polysaccharide vaccine (PPV23) was given at the same time as the Shingrix vaccine when compared to when Shingrix was given alone.
Facing issue in account approval? email us at info@ipt.pw